Intellipharmaceutics International Inc. (IPCI)

[fabius]

Seriously ??

"Acura is working on very similar concept. They're multiple years ahead of IPCI, they have funding, and they have an actual research staff-- none of which IPCI currently has. "

from august SEC 10Q:

"We estimate that our current unrestricted cash, cash equivalent and marketable securities will be sufficient to fund the development of our products utilizing our Limitx and Impede Technologies, the commercialization of our Nexafed products and our related operating expenses through November 2016 while maintaining compliance with the $2.5 million compensating balance requirement under our term loan with Oxford Finance LLC. At August 5, 2016, we had unrestricted cash, cash equivalents and marketable securities (after deduction of the $2.5 million compensating balance requirement under our term loan with Oxford) of $3.4 million. To fund further operations and product development activities, we must raise additional financing or enter into license or collaboration agreements with
third parties relating to our technologies."